Her scientific interests lie mostly in Virology, Antibody, Virus, Epitope and Neutralization. Celia C. LaBranche specializes in Virology, namely Neutralizing antibody. Her studies in Antibody integrate themes in fields like Protein structure, Molecular biology, T cell and Antigen.
The Infectivity, Lentivirus and Titer research Celia C. LaBranche does as part of her general Virus study is frequently linked to other disciplines of science, such as Betacoronavirus, therefore creating a link between diverse domains of science. Her biological study spans a wide range of topics, including Mutagenesis and Binding site. Her Neutralization research includes themes of Viral envelope, Gp41 and Antigenicity.
Virology, Antibody, Immunology, Virus and Epitope are her primary areas of study. Her studies deal with areas such as HIV vaccine and Immune system, Immunogenicity as well as Virology. The study incorporates disciplines such as Glycoprotein, Glycan and Antigen in addition to Antibody.
Her Simian immunodeficiency virus, Vaccination, Immunization and Antibody-dependent cell-mediated cytotoxicity study, which is part of a larger body of work in Immunology, is frequently linked to Macaque, bridging the gap between disciplines. Her study in Virus is interdisciplinary in nature, drawing from both Vaccinia and Heterologous. In her research on the topic of Epitope, Cell fusion is strongly related with Molecular biology.
Her main research concerns Antibody, Virology, Neutralization, Immune system and Epitope. Her work carried out in the field of Antibody brings together such families of science as HIV vaccine and Vaccination. Her Virology study combines topics from a wide range of disciplines, such as Glycoprotein, Glycan and Immunogenicity.
Her Immunogenicity research focuses on Antigen presentation and how it connects with Antigen. Her research investigates the connection between Epitope and topics such as Polyclonal antibodies that intersect with issues in Recombinant DNA and Ectodomain. In Virus, Celia C. LaBranche works on issues like Peptide, which are connected to Peptide vaccine and Cytotoxicity.
Celia C. LaBranche mostly deals with Antibody, Virology, Immune system, Virus and Monoclonal antibody. She combines subjects such as Antigen and Immunity with her study of Antibody. Her research in Immune system focuses on subjects like HIV vaccine, which are connected to Viral vector.
Her study in Virus concentrates on Neutralization and Infectivity. Celia C. LaBranche has included themes like Titer, Genetic variation and Viral load in her Infectivity study. Her work deals with themes such as Epitope and Glycoprotein, Glycan, which intersect with Monoclonal antibody.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus.
Bette Korber;Will M. Fischer;Sandrasegaram Gnanakaran;Hyejin Yoon.
HIV-1 neutralizing antibodies induced by native-like envelope trimers
Rogier W. Sanders;Rogier W. Sanders;Marit J. Van Gils;Ronald Derking;Devin Sok;Devin Sok.
Spike mutation pipeline reveals the emergence of a more transmissible form of SARS-CoV-2
Bette Korber;Will Fischer;S. Gnana Gnanakaran;Heyjin Yoon.
Stable exposure of the coreceptor-binding site in a CD4-independent HIV-1 envelope protein
Trevor L. Hoffman;Celia C. LaBranche;Wentao Zhang;Gabriella Canziani.
Proceedings of the National Academy of Sciences of the United States of America (1999)
Magnitude and Breadth of the Neutralizing Antibody Response in the RV144 and Vax003 HIV-1 Vaccine Efficacy Trials
David C. Montefiori;Chitraporn Karnasuta;Ying Huang;Hasan Ahmed.
The Journal of Infectious Diseases (2012)
Immunogenicity of Stabilized HIV-1 Envelope Trimers with Reduced Exposure of Non-neutralizing Epitopes
Steven W. de Taeye;Gabriel Ozorowski;Alba Torrents de la Peña;Miklos Guttman.
Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responses.
Norbert Pardi;Michael J. Hogan;Martin S. Naradikian;Kaela Parkhouse.
Journal of Experimental Medicine (2018)
D614G Spike Mutation Increases SARS CoV-2 Susceptibility to Neutralization.
Drew Weissman;Mohamad Gabriel Alameh;Thushan de Silva;Paul Collini.
Cell Host & Microbe (2021)
Global Panel of HIV-1 Env Reference Strains for Standardized Assessments of Vaccine-Elicited Neutralizing Antibodies
Allan deCamp;Peter Hraber;Robert T. Bailer;Michael S. Seaman.
Journal of Virology (2014)
Elicitation of Robust Tier 2 Neutralizing Antibody Responses in Nonhuman Primates by HIV Envelope Trimer Immunization Using Optimized Approaches.
Matthias Pauthner;Colin Havenar-Daughton;Colin Havenar-Daughton;Devin Sok;Joseph P. Nkolola;Joseph P. Nkolola.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: